help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hennemann, G.
Right arrow Articles by Van Zijl, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hennemann, G.
Right arrow Articles by Van Zijl, J.

Journal of Clinical Endocrinology & Metabolism, Vol 40, 935-941, Copyright © 1975 by Endocrine Society

ARTICLES

Dissociation of serum LATS activity and hyperfunction and autonomy of the thyroid gland in Graves' disease

G Hennemann, A Dolman, R Docter, A De Reus and J Van Zijl

LATS was measured with the double isotope technique in IgG serum concentrates of 23 patients with Graves' disease before treatment and of 18 patients during treatment with carbimazole and triiodothyronine. LATS activity was present in 18 out of 23 patients before treatment (78%). When the second measurement was taken into account the incidence did increase to 95%. No difference could be found in the mean values of total thyroxine, thyroid 131-I uptake and thyroid weight of the group of LATS positive and LATS negative patients before treatment. Also no relation could be established between LATS activity and suppressibility of thyroid 131-I uptake during treatment. It was found that LATS positive patients who suppress during therapy have lower initial LATS blood levels than LATS positive patients who remain unsuppressed. It is concluded that it is more likely that LATS is a "marker" of Graves' disease rather than the cause of the hyperthyroidism.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1975 by The Endocrine Society